The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer
about
Parallel Aspects of the Microenvironment in Cancer and Autoimmune DiseasePeripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapyHeterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategiesStroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung CancerInterferon-γ and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironmentTumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery.The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancerEmodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease.The Microenvironmental Effect in the Progression, Metastasis, and Dormancy of Breast Cancer: A Model System within Bone Marrow.Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer.Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.Cellular and molecular immunology of lung cancer: therapeutic implications.Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic modelTumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patientsInflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis.Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis.Influence of human immune cells on cancer: studies at the University of Colorado.Anti-tumour strategies aiming to target tumour-associated macrophages.S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.Clinical evaluation of systemic and local immune responses in cancer: time for integration.Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer.The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer.Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy.Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy.Immune Therapy.Metformin affects the features of a human hepatocellular cell line (HepG2) by regulating macrophage polarization in a co-culture microenviroment.Role of tumor-associated macrophages in human malignancies: friend or foe?Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges.Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases.Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.Prognostic significance of the absolute monocyte counts in lung cancer patients with venous thromboembolism.Macrophages, Inflammation, and Lung Cancer.Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer.The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy.Clinical significance of the tumor microenvironment in non-small cell lung cancer.
P2860
Q26753174-80E7F293-694A-4943-9AA7-69F874D1DF16Q28394867-0DBC59A0-64FF-45B2-A4E5-A3697861792CQ30275647-A1A2DF93-AD4B-4D4B-8598-F70242A6A418Q33837289-73E2CF4F-E4E4-4766-888E-AFDC74A30444Q34273676-AE7E11E2-4657-4746-A84C-481AA59E0D91Q34420618-8FDB4549-E064-4040-B57E-18876A91A406Q34450525-D3E05B16-5A6F-412E-AFEB-274B125D9717Q34475456-D169A86F-05EE-4825-9D5F-DE0133DFB38AQ34502899-00F335DA-36A3-431C-B639-9E92BC02237DQ34899176-6AC430B9-CD57-443A-B51C-C088264BFAE2Q35810653-EBB85DA3-4AC1-4692-ABFC-9DEBF78EF9D3Q35922142-1D72E35B-409E-4A12-BAF1-7BECB86E8901Q36044341-81BE6DE4-B944-4F19-A052-FCEFAC18337DQ36051547-B0C564B2-1203-481F-8447-0763781E65CCQ36130505-CBD53116-EB80-4C9F-B7EF-D45B82066513Q36245385-AD6672B6-FD2D-4417-A6D0-DD3ADE30A309Q36383090-AAF3CEDC-4A3D-4011-8C31-49C5C7110E43Q36946671-7972A4CF-58E0-48E4-90E9-9534731A03ADQ36980064-D08C6E29-AAA8-4914-AA98-7A2D4E2415CCQ37376238-743A4343-8325-4649-ABD3-5D75306E1244Q37457913-B98B7CBA-2A21-481B-8C20-ADE19716FAB0Q37698684-7A48A0FA-4E93-4546-ABEF-FDD8B57514A1Q38056746-D232468A-1833-4DF3-B0F5-D26C83FFD99CQ38061123-181960FE-88FE-40FA-9FDB-E15A868F18DCQ38150174-DAAC42B6-D002-4220-A32D-AB3A64A510BAQ38246950-140C8D0F-778B-40AA-BDDB-91A6FC8F8E83Q38296670-9D87B820-D707-4181-AA53-56B243BB33B7Q38390089-16AF82B0-DC4D-4A4A-8A79-7553A50E3331Q38541767-CC8D922B-2FEB-41CC-9F35-79F9F6BBBB71Q38669273-29E79803-4A51-47B7-AC25-0FE0B2D165B3Q38827905-82DF653D-2423-44CA-AB2C-45AA45E6B725Q38904869-C11690BE-BB7C-4A2E-B7C1-65AED6847ADAQ38958680-C5972EC8-6251-4F49-862B-0308022C3D9CQ39210540-6F76CAF9-0C68-46E9-A807-C76B6D732D7EQ39321597-369E4149-EC38-41B8-81CE-B464EB07F1BAQ41002912-94588EFF-A333-4844-80D6-C824B934EF29Q41113415-4623A503-38A0-4891-96BD-0F28C71E991AQ41142487-6AC1EB3A-D2C7-4322-8AAE-64DE986A22E1Q41149149-B2BF42C6-FD91-4883-A462-D66831A5424AQ42107277-BD27D4FF-D720-4697-AA71-3681955E962F
P2860
The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The number and microlocalizati ...... in non-small cell lung cancer
@ast
The number and microlocalizati ...... in non-small cell lung cancer
@en
The number and microlocalizati ...... in non-small cell lung cancer.
@nl
type
label
The number and microlocalizati ...... in non-small cell lung cancer
@ast
The number and microlocalizati ...... in non-small cell lung cancer
@en
The number and microlocalizati ...... in non-small cell lung cancer.
@nl
prefLabel
The number and microlocalizati ...... in non-small cell lung cancer
@ast
The number and microlocalizati ...... in non-small cell lung cancer
@en
The number and microlocalizati ...... in non-small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
The number and microlocalizati ...... in non-small cell lung cancer
@en
P2093
Fuqiang Dai
Guowei Che
Junliang Ma
Shangfu Zhang
P2860
P2888
P356
10.1186/1471-2407-10-220
P407
P50
P577
2010-05-20T00:00:00Z
P5875
P6179
1041068940